Nanoparticle mRNA Vaccins against Coronavirus and Emerging Variants (Q3989360): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in de: Adding German translations)
(‎Removed claims)
Property / start time
1 April 2021
Timestamp+2021-04-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / start time: 1 April 2021 / rank
Normal rank
 
Property / start time
31 March 2023
Timestamp+2023-03-31T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / start time: 31 March 2023 / rank
Normal rank
 

Revision as of 10:56, 14 December 2021

Project Q3989360 in Netherlands
Language Label Description Also known as
English
Nanoparticle mRNA Vaccins against Coronavirus and Emerging Variants
Project Q3989360 in Netherlands

    Statements

    contained in NUTS
    Twente
    0 references
    EU contribution
    293,087.67 Euro
    0 references
    budget
    1,434,730.4 Euro
    0 references
    co-financing rate
    20.428 percent
    0 references
    beneficiary name (string)
    20Med Therapeutics
    0 references
    beneficiary
    Q3986713
    0 references
    coordinate location

    52°14'25.08"N, 6°51'14.04"E
    0 references
    postal code
    7522 NB
    0 references

    Identifiers

    Netherlands Kohesio ID
    OP-2014-2023-Oost-PROJ-01040
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3989360&oldid=19527665"